The possible introduction of tariffs in the U.S. on pharmaceutical imports won't stop Italy's Chiesi Group from supplying patients in need of its products, CEO Giuseppe Accogli told Reuters on ...

A shuttered Milanese manufacturing site with a storied history is getting a new lease on life, thanks to a nearly half-a-billion-dollar investment from Italian drugmaker Chiesi. As part of an ...

Chiesi is hoping real world evidence will show its latest COPD triple therapy can help cut hospital admissions for the disease. Trimbow (beclometasone+formoterol+glycopyrronium) combines an ...

the company is sponsoring two symposia focused on improving patient quality of life in asthma and COPD and will present during a poster session findings from the TANGO trial, where Chiesi is ...

Asthma is an airway inflammatory disease characterized ... Boehringer Ingelheim, Chiesi, GlaxoSmithKline, MSD, Menarini, Novartis and Nycomed. The authors have no other relevant affiliations ...

Family-owned Chiesi, based in the northern Italian city of Parma, provides treatment for rare diseases and respiratory conditions such as asthma and COPD. Sign up here. Chiesi plans to press ahead ...